Old Web
English
Sign In
Acemap
>
authorDetail
>
Charlene Gutierrez
Charlene Gutierrez
University of California, San Diego
Immunology
Medicine
Chronic lymphocytic leukemia
Leukemia
Progressive disease
3
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Durable and Specific Inhibition of ROR1 Signaling Associates with Prolonged Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Treated with Cirmtuzumab
2017
Blood
Michael Y. Choi
George F. Widhopf
Jian Yu
Liguang Chen
Md. Kamrul Hasan
Laura Z. Rassenti
Emily Pittman
Karen Messer
Charlene Gutierrez
Reilly L Kidwell
Charles Prussak
Januario E. Castro
Catriona Jamieson
Thomas J. Kipps
Show All
Source
Cite
Save
Citations (3)
A Phase 1 Clinical Trial of Cirmtuzumab, a First-in-Class ROR1 Inhibiting Antibody, for the Treatment of Patients with Relapsed or Refractory CLL: Interim Analysis
2016
Clinical Lymphoma, Myeloma & Leukemia
Michael Y. Choi
Catriona Jamieson
George F. Widhopf
Jian Yu
Januario E. Castro
Reilly L Kidwell
Hongying Li
Tiffany Juarez
Susette Gorak
Emily Pittman
Charlene Gutierrez
Laura Z. Rassenti
Karen Messer
Charles Prussak
Thomas J. Kipps
Show All
Source
Cite
Save
Citations (0)
Immunotherapeutic Targeting of ROR1-Dependent, Non-Canonical Wnt5a-Signaling By Cirmtuzumab: A First-in-Human Phase I Trial for Patients with Intractable Chronic Lymphocytic Leukemia
2016
Blood
Michael Y. Choi
George F. Widhopf
Jian Yu
Reilly L Kidwell
Laura Z. Rassenti
Charlene Gutierrez
Susette Gorak
Tiffany Juarez
Emily Pittman
Hongying Li
Karen Messer
Charles Prussak
Januario E. Castro
Catriona Jamieson
Thomas J. Kipps
Show All
Source
Cite
Save
Citations (2)
1